Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NVCR Novocure > Detailed Quotes

NVCR Novocure

Watchlist
73.480
-4.520-5.79%
Close  12/06 16:00 ET
73.4800.0000.00%
Post Mkt Price 12/06 16:06 ET
High
78.780
Open
78.040
Turnover
38.62M
Low
72.840
Pre Close
78.000
Volume
521.04K
Market Cap
7.71B
P/E(TTM)
Loss
52wk High
90.980
Shares
104.95M
P/E(Static)
Loss
52wk Low
56.390
Float Cap
7.61B
Bid/Ask %
0.00%
Historical High
232.760
Shs Float
103.58M
Volume Ratio
0.76
Historical Low
5.950
Dividend TTM
--
Div Yield TTM
--
P/B
17.31
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.50%
Amplitude
7.62%
Avg Price
74.115
Lot Size
1
Float Cap
7.61B
Bid/Ask %
0.00%
Historical High
232.760
Shs Float
103.58M
Volume Ratio
0.76
Historical Low
5.950
Dividend TTM
--
P/B
17.31
Dividend LFY
--
Turnover Ratio
0.50%
Amplitude
7.62%
Avg Price
74.115
Lot Size
1
Price Forecast

News

Comment

Company Overview More
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
CEO: Mr. Asaf Danziger
Market: NASDAQ
Listing Date: 10/02/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist